These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18423442)

  • 1. The use of the hippocampal slice preparation in the study of Alzheimer's disease.
    Fitzjohn SM; Doherty AJ; Collingridge GL
    Eur J Pharmacol; 2008 May; 585(1):50-9. PubMed ID: 18423442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
    Danysz W; Parsons CG
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
    Motawaj M; Burban A; Davenas E; Arrang JM
    J Pharmacol Exp Ther; 2011 Feb; 336(2):479-87. PubMed ID: 21057059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior.
    Amin SN; El-Aidi AA; Ali MM; Attia YM; Rashed LA
    Neuromolecular Med; 2015 Jun; 17(2):121-36. PubMed ID: 25680935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
    Koutsilieri E; Riederer P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
    Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
    Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
    Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices.
    Rouaud E; Billard JM
    Br J Pharmacol; 2003 Nov; 140(6):1051-6. PubMed ID: 14530208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.
    Yao L; Zhou Q
    Neural Plast; 2017; 2017():2875904. PubMed ID: 28163934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
    Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
    Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alzheimer's disease drug memantine increases the number of radial glia-like progenitor cells in adult hippocampus.
    Namba T; Maekawa M; Yuasa S; Kohsaka S; Uchino S
    Glia; 2009 Aug; 57(10):1082-90. PubMed ID: 19115386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil.
    Ota H; Ogawa S; Ouchi Y; Akishita M
    Exp Gerontol; 2015 Dec; 72():109-16. PubMed ID: 26408226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.